PainReform (NASDAQ:PRFX) stock is falling on Wednesday after the company announced a concurrent registered direct offering and private placement.
The registered direct offering has PainReform agreeing to sell 301,230 shares of PRFX stock at a price of $9 per share. The private placement has it issuing unregistered warrants to buy up to 301,230 shares of its stock. These warrants will also have an exercise price of $9 per share.
PainReform notes that it expects to raise some $2.7 million from the offering and private placement. It will use these funds to fuel its research and development and clinical trials, as well as for working capital and general corporate purposes.
Recent PRFX Stock Volatility
It’s not just this news that explains why PRFX stock is down today. Instead, the company’s shares are also giving up some of the gains they saw during normal trading hours on Tuesday. Shares of PRFX stock underwent a massive rally, closing out Tuesday up 307.4%.
That incredible rise in price came alongside heavy trading of PainReform’s shares. That saw some 10.7 million shares change hands by the time markets closed yesterday. For comparison, the company’s daily average trading volume is about 331,000 shares.
As for stock movement today, some 407,000 shares of PRFX stock have changed hands this morning. That has the stock down 40% as of this writing.
Investors can find even more of the most recent stock market news down below!
We’ve got all of the hottest stock market coverage that traders will want to read about on Wednesday! Some examples of that include why shares of ShiftPixy (NASDAQ:PIXY), Cadrenal Therapeutics (NASDAQ:CVKD), and Healthcare Triangle (NASDAQ:HCTI) stock are moving today. All of that news is readily available below!
More Stock Market News for Wednesday
- Why Is ShiftPixy (PIXY) Stock Down 31% Today?
- Why Is Cadrenal Therapeutics (CVKD) Stock Up 71% Today?
- Why Is Healthcare Triangle (HCTI) Stock Up 124% Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risk.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.